Hypertonic Saline/Dextran for Cardiopulmonary Bypass Reduces Gut Tissue Water but Does Not Improve Mucosal Perfusion

Weike Tao, Joseph B. Zwischenberger, Thuan T. Nguyen, Roger A. Vertrees, Leta K. Nutt, Laura B. McDaniel, George Kramer

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Gut mucosal ischemia has been associated with cardiopulmonary bypass (CPB) and may contribute to postoperative systemic inflammatory response and multiorgan dysfunction. Hypertonic saline/dextran (HSD) has been previously shown to selectively increase mucosal blood flow in circulatory shock. To determine whether adding HSD to the prime solution for CPB improves gut mucosal blood flow and oxygenation, we performed normothermic, non-cross-clamped CPB in pigs with 1 ml/kg of HSD (25% NaCl/24% dextran 70) (HSD group, n = 9) or lactated Ringer's solution (LRS group, n = 9) as control added to a standard prime. Animals were instrumented with ultrasonic flow probes on the superior mesenteric artery (SMA), laser Doppler mucosal flow probes in the ileum, and indwelling portal vein catheters and tonometers for mucosal hydrogen ion measurements and pH calculations in the stomach, ileum, and rectum. The total infused volume and net fluid balance was significantly lower in the HSD than in the LRS group (649 ± 171 ml vs 2075 ± 385 ml and 502 ± 182 ml vs 1891 ± 363 ml, respectively, P 0.01). SMA flow in the LRS group increased to 110-123% of baseline during CPB and was significantly higher than that in the HSD group which remained unchanged. Ileal mucosal blood flow decreased significantly to 70-50% of baseline in both groups with no difference between groups. Gut oxygen (O2) delivery decreased during CPB in both groups, but O2 consumption remained unchanged. Gastric ileal, and rectal mucosal pH decreased progressively, and portal venous blood pH also decreased in both groups, but there was no significant difference between groups. The HSD group had 34.5% less water content in the duodenum (P < 0.01), 28.2% less in jejunum, and 18.9% less in colon than the LRS group (P < 0.05). We conclude HSD added to the prime for CPB-reduced volume requirements and gut tissue water, but did not improve mucosal perfusion or prevent mucosal acidosis.

Original languageEnglish (US)
Pages (from-to)718-725
Number of pages8
JournalJournal of Surgical Research
Volume57
Issue number6
DOIs
StatePublished - Dec 1994

Fingerprint

dextran - saline drug combination
Cardiopulmonary Bypass
Perfusion
Water
Superior Mesenteric Artery
Ileum
Stomach
Water-Electrolyte Balance
Jejunum
Portal Vein
Acidosis
Dextrans
Duodenum
Rectum
Ultrasonics
Protons
Shock
Colon
Lasers
Swine

ASJC Scopus subject areas

  • Surgery

Cite this

Hypertonic Saline/Dextran for Cardiopulmonary Bypass Reduces Gut Tissue Water but Does Not Improve Mucosal Perfusion. / Tao, Weike; Zwischenberger, Joseph B.; Nguyen, Thuan T.; Vertrees, Roger A.; Nutt, Leta K.; McDaniel, Laura B.; Kramer, George.

In: Journal of Surgical Research, Vol. 57, No. 6, 12.1994, p. 718-725.

Research output: Contribution to journalArticle

Tao, Weike ; Zwischenberger, Joseph B. ; Nguyen, Thuan T. ; Vertrees, Roger A. ; Nutt, Leta K. ; McDaniel, Laura B. ; Kramer, George. / Hypertonic Saline/Dextran for Cardiopulmonary Bypass Reduces Gut Tissue Water but Does Not Improve Mucosal Perfusion. In: Journal of Surgical Research. 1994 ; Vol. 57, No. 6. pp. 718-725.
@article{281136ac828f4b8da9fa1d0a5af38d51,
title = "Hypertonic Saline/Dextran for Cardiopulmonary Bypass Reduces Gut Tissue Water but Does Not Improve Mucosal Perfusion",
abstract = "Gut mucosal ischemia has been associated with cardiopulmonary bypass (CPB) and may contribute to postoperative systemic inflammatory response and multiorgan dysfunction. Hypertonic saline/dextran (HSD) has been previously shown to selectively increase mucosal blood flow in circulatory shock. To determine whether adding HSD to the prime solution for CPB improves gut mucosal blood flow and oxygenation, we performed normothermic, non-cross-clamped CPB in pigs with 1 ml/kg of HSD (25{\%} NaCl/24{\%} dextran 70) (HSD group, n = 9) or lactated Ringer's solution (LRS group, n = 9) as control added to a standard prime. Animals were instrumented with ultrasonic flow probes on the superior mesenteric artery (SMA), laser Doppler mucosal flow probes in the ileum, and indwelling portal vein catheters and tonometers for mucosal hydrogen ion measurements and pH calculations in the stomach, ileum, and rectum. The total infused volume and net fluid balance was significantly lower in the HSD than in the LRS group (649 ± 171 ml vs 2075 ± 385 ml and 502 ± 182 ml vs 1891 ± 363 ml, respectively, P 0.01). SMA flow in the LRS group increased to 110-123{\%} of baseline during CPB and was significantly higher than that in the HSD group which remained unchanged. Ileal mucosal blood flow decreased significantly to 70-50{\%} of baseline in both groups with no difference between groups. Gut oxygen (O2) delivery decreased during CPB in both groups, but O2 consumption remained unchanged. Gastric ileal, and rectal mucosal pH decreased progressively, and portal venous blood pH also decreased in both groups, but there was no significant difference between groups. The HSD group had 34.5{\%} less water content in the duodenum (P < 0.01), 28.2{\%} less in jejunum, and 18.9{\%} less in colon than the LRS group (P < 0.05). We conclude HSD added to the prime for CPB-reduced volume requirements and gut tissue water, but did not improve mucosal perfusion or prevent mucosal acidosis.",
author = "Weike Tao and Zwischenberger, {Joseph B.} and Nguyen, {Thuan T.} and Vertrees, {Roger A.} and Nutt, {Leta K.} and McDaniel, {Laura B.} and George Kramer",
year = "1994",
month = "12",
doi = "10.1006/jsre.1994.1207",
language = "English (US)",
volume = "57",
pages = "718--725",
journal = "Journal of Surgical Research",
issn = "0022-4804",
publisher = "Academic Press Inc.",
number = "6",

}

TY - JOUR

T1 - Hypertonic Saline/Dextran for Cardiopulmonary Bypass Reduces Gut Tissue Water but Does Not Improve Mucosal Perfusion

AU - Tao, Weike

AU - Zwischenberger, Joseph B.

AU - Nguyen, Thuan T.

AU - Vertrees, Roger A.

AU - Nutt, Leta K.

AU - McDaniel, Laura B.

AU - Kramer, George

PY - 1994/12

Y1 - 1994/12

N2 - Gut mucosal ischemia has been associated with cardiopulmonary bypass (CPB) and may contribute to postoperative systemic inflammatory response and multiorgan dysfunction. Hypertonic saline/dextran (HSD) has been previously shown to selectively increase mucosal blood flow in circulatory shock. To determine whether adding HSD to the prime solution for CPB improves gut mucosal blood flow and oxygenation, we performed normothermic, non-cross-clamped CPB in pigs with 1 ml/kg of HSD (25% NaCl/24% dextran 70) (HSD group, n = 9) or lactated Ringer's solution (LRS group, n = 9) as control added to a standard prime. Animals were instrumented with ultrasonic flow probes on the superior mesenteric artery (SMA), laser Doppler mucosal flow probes in the ileum, and indwelling portal vein catheters and tonometers for mucosal hydrogen ion measurements and pH calculations in the stomach, ileum, and rectum. The total infused volume and net fluid balance was significantly lower in the HSD than in the LRS group (649 ± 171 ml vs 2075 ± 385 ml and 502 ± 182 ml vs 1891 ± 363 ml, respectively, P 0.01). SMA flow in the LRS group increased to 110-123% of baseline during CPB and was significantly higher than that in the HSD group which remained unchanged. Ileal mucosal blood flow decreased significantly to 70-50% of baseline in both groups with no difference between groups. Gut oxygen (O2) delivery decreased during CPB in both groups, but O2 consumption remained unchanged. Gastric ileal, and rectal mucosal pH decreased progressively, and portal venous blood pH also decreased in both groups, but there was no significant difference between groups. The HSD group had 34.5% less water content in the duodenum (P < 0.01), 28.2% less in jejunum, and 18.9% less in colon than the LRS group (P < 0.05). We conclude HSD added to the prime for CPB-reduced volume requirements and gut tissue water, but did not improve mucosal perfusion or prevent mucosal acidosis.

AB - Gut mucosal ischemia has been associated with cardiopulmonary bypass (CPB) and may contribute to postoperative systemic inflammatory response and multiorgan dysfunction. Hypertonic saline/dextran (HSD) has been previously shown to selectively increase mucosal blood flow in circulatory shock. To determine whether adding HSD to the prime solution for CPB improves gut mucosal blood flow and oxygenation, we performed normothermic, non-cross-clamped CPB in pigs with 1 ml/kg of HSD (25% NaCl/24% dextran 70) (HSD group, n = 9) or lactated Ringer's solution (LRS group, n = 9) as control added to a standard prime. Animals were instrumented with ultrasonic flow probes on the superior mesenteric artery (SMA), laser Doppler mucosal flow probes in the ileum, and indwelling portal vein catheters and tonometers for mucosal hydrogen ion measurements and pH calculations in the stomach, ileum, and rectum. The total infused volume and net fluid balance was significantly lower in the HSD than in the LRS group (649 ± 171 ml vs 2075 ± 385 ml and 502 ± 182 ml vs 1891 ± 363 ml, respectively, P 0.01). SMA flow in the LRS group increased to 110-123% of baseline during CPB and was significantly higher than that in the HSD group which remained unchanged. Ileal mucosal blood flow decreased significantly to 70-50% of baseline in both groups with no difference between groups. Gut oxygen (O2) delivery decreased during CPB in both groups, but O2 consumption remained unchanged. Gastric ileal, and rectal mucosal pH decreased progressively, and portal venous blood pH also decreased in both groups, but there was no significant difference between groups. The HSD group had 34.5% less water content in the duodenum (P < 0.01), 28.2% less in jejunum, and 18.9% less in colon than the LRS group (P < 0.05). We conclude HSD added to the prime for CPB-reduced volume requirements and gut tissue water, but did not improve mucosal perfusion or prevent mucosal acidosis.

UR - http://www.scopus.com/inward/record.url?scp=0028607373&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028607373&partnerID=8YFLogxK

U2 - 10.1006/jsre.1994.1207

DO - 10.1006/jsre.1994.1207

M3 - Article

VL - 57

SP - 718

EP - 725

JO - Journal of Surgical Research

JF - Journal of Surgical Research

SN - 0022-4804

IS - 6

ER -